Literature DB >> 10195974

Recent advances in haematology.

D Provan1, D F O'Shaughnessy.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10195974      PMCID: PMC1115421          DOI: 10.1136/bmj.318.7189.991

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  29 in total

1.  APC-resistance and Mnl I genotype (Gln 506) of coagulation factor V are rare in Japanese population.

Authors:  O Takamiya; F Ishida; H Kodaira; K Kitano
Journal:  Thromb Haemost       Date:  1995-09       Impact factor: 5.249

2.  World distribution of factor V Leiden.

Authors:  D C Rees; M Cox; J B Clegg
Journal:  Lancet       Date:  1995-10-28       Impact factor: 79.321

3.  Mutation in blood coagulation factor V associated with resistance to activated protein C.

Authors:  R M Bertina; B P Koeleman; T Koster; F R Rosendaal; R J Dirven; H de Ronde; P A van der Velden; P H Reitsma
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

4.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

5.  Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trial.

Authors:  E Bayever; P L Iversen; M R Bishop; J G Sharp; H K Tewary; M A Arneson; S J Pirruccello; R W Ruddon; A Kessinger; G Zon
Journal:  Antisense Res Dev       Date:  1993

6.  Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion.

Authors:  H Uchiyama; B A Barut; A F Mohrbacher; D Chauhan; K C Anderson
Journal:  Blood       Date:  1993-12-15       Impact factor: 22.113

7.  High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)

Authors:  F R Rosendaal; T Koster; J P Vandenbroucke; P H Reitsma
Journal:  Blood       Date:  1995-03-15       Impact factor: 22.113

8.  Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.

Authors:  T Koster; F R Rosendaal; H de Ronde; E Briët; J P Vandenbroucke; R M Bertina
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321

9.  Interleukin-6 inhibits apoptosis of malignant plasma cells.

Authors:  A Lichtenstein; Y Tu; C Fady; R Vescio; J Berenson
Journal:  Cell Immunol       Date:  1995-05       Impact factor: 4.868

10.  Homozygosity for a novel missense mutation in the prothrombin gene causing a severe bleeding disorder.

Authors:  S R Poort; J J Michiels; P H Reitsma; R M Bertina
Journal:  Thromb Haemost       Date:  1994-12       Impact factor: 5.249

View more
  1 in total

1.  Imprinting of Mesenchymal Stromal Cell Transcriptome Persists even after Treatment in Patients with Multiple Myeloma.

Authors:  Léa Lemaitre; Laura DoSouto Ferreira; Marie-Véronique Joubert; Hervé Avet-Loiseau; Ludovic Martinet; Jill Corre; Bettina Couderc
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.